Search Results 751-760 of 16374 for monoclonal antibody

  1. A Phase 1 Trial of MK-4280 as Monotherapy and in Combination with Pembrolizumab with or without Chemotherapy or Lenvatinib (E7080/MK 7902) in Subjects with Advanced Solid Tumors - Mayo Clinic

    Subjects enrolled in the PD-1-treatment-failure HNSCC cohort must be refractory to an FDA approved anti-PD-1/PD-L1 monoclonal antibody ... antibodies), or ...

  2. Publications - Pablo Moreno Franco, M.D. - Mayo Clinic

    ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Shah SZ, Alvarez FG, Sanghavi ...

  3. MAYO MAGAZINE - Autumn 2008 - MC2386-AU08

    “BEXXAR is an intravenous monoclonal antibody that's directed against the proteins located ... Monoclonal antibodies identify the bad cancer cells and ...

  4. Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) - Mayo Clinic

    * previous severe hypersensitivity reaction to treatment with another monoclonal antibody (mAb) * active autoimmune disease requiring immunosuppressive ...

  5. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Monoclonal antibody treatment for multiple myeloma within 21 days;; Cytotoxic therapy within 14 days;; Proteasome inhibitor therapy within 14 days ...

  6. Rabies immune globulin (intramuscular route) - Mayo Clinic

    Rabies immune globulin is used together with rabies vaccine to prevent infection caused by the rabies virus. It works by giving your body the antibodies it ...

  7. Radiation Therapy Clinical Trials

    Monoclonal antibodies, such as durvalumab and tremelimumab, may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high ...

  8. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

    Any prior treatment with CD38 targeting monoclonal antibodies, including daratumumab or isatuximab-irfc;; Administration of the Janssen COVID-19 vaccine ...

  9. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody therapy; Palliative radiation therapy is permitted if clinically indicated and not indicative of progressive disease. Participating Mayo ...

  10. Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease - Mayo Clinic

    This observational study will collect blood samples to measure sustained antibody concentrations to evaluate seroprevalence and study immunity at 6 and 12 ...